Gene therapy: evidence, value and affordability in the US health care system

DEVELOPMENTS IN VALUE FRAMEWORKS TO INFORM THE ALLOCATION OF HEALTHCARE RESOURCES

(2017) Wija Oortwijn et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Overcoming Challenges Facing Advanced Therapies in the EU Market

(2016) Mohamed Abou-El-Enein et al.   Cell Stem Cell

Putting a price tag on novel autologous cellular therapies

(2016) Mohamed Abou-El-Enein et al.   CYTOTHERAPY

Buying cures versus renting health: Financing health care with consumer loans

(2016) Vahid Montazerhodjat et al.   Science Translational Medicine

Glybera's Second Act: The Curtain Rises on the High Cost of Therapy

(2015) Seppo Ylä-Herttuala   MOLECULAR THERAPY

Measuring the Value of Prescription Drugs

(2015) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement

(2015) Tania Bubela et al.   Regenerative Medicine

Clinical development success rates for investigational drugs

(2014) Michael Hay et al.   NATURE BIOTECHNOLOGY

APPROACHES TO IDENTIFYING, MEASURING, AND AGGREGATING ELEMENTS OF VALUE

(2013) Adrian Towse et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

(2013) Louis P. Garrison et al.   VALUE IN HEALTH